Yang Xu, PhD (he/him/his)

Assistant Professor
Peking University Health Science Center, China (People's Republic)

Dr. Yang Xu is from the School of Pharmaceutical Sciences, Peking University Health Science Center, China and specializes in pharmaco-epidemiology, statistics, and renal diseases. He has published related papers in high-ranking journals including Diabetes Care, Kidney International, and Pharmacoepidemiology and Drug Safety. For the upcoming ISPE 2024 annual meeting, Dr. Yang Xu and his team have prepared a real-world evidence study titled “The Effect of Sodium Glucose Cotransporter-2 Inhibitors on HbA1c Variability and Acute Kidney Injury: A Causal Mediation Analysis”.

Poster(s):

• (251) Dynamic containment strategy in critical ill patients with high risk of antibiotic drug resistance, a MIMIC-IV study
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (263) Human albumin for adults with sepsis: an updated systematic review and meta-analysis of randomized controlled trials
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (BSPOT47) The Effect of Sodium Glucose Cotransporter-2 Inhibitors on HbA1c Variability and Acute Kidney Injury: A Causal Mediation Analysis
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST